Aspergillosis

Aspergillosis is a devastating fungal infection that poses one of the most significant health threats to raptors in both captive and wild populations. This disease is caused by fungi of the genus Aspergillus, with Aspergillus fumigatus being the most commonly implicated species in birds of prey. The infection primarily affects the respiratory system, including the lungs, air sacs, and syrinx (voice box), though systemic spread to other organs can occur in advanced cases. Aspergillosis is considered the most important fungal disease affecting captive raptors and represents a leading cause of death in rehabilitation centers and falconry operations worldwide.

The causative organism, Aspergillus fumigatus, is a ubiquitous mold found in soil, decaying organic matter, and contaminated grain or hay. Raptors become infected by inhaling fungal spores (conidia) that germinate and establish infection within the respiratory tract. Unlike bacterial or viral infections, aspergillosis is not contagious between birds; each case results from environmental exposure. The fungus thrives in the unique avian respiratory system, which includes extensive air sacs that provide an ideal warm, moist environment for fungal growth. Certain raptor species, particularly those from arctic or cold climates such as Gyrfalcons and Snowy Owls, appear especially susceptible to infection.

The impact of aspergillosis on raptor health is profound and often devastating. The fungus causes granulomatous lesions (aspergillomas) that progressively destroy lung and air sac tissue, leading to respiratory compromise, exercise intolerance, and eventually respiratory failure. The infection triggers a severe inflammatory response that further damages respiratory tissues. In systemic cases, fungal granulomas may develop in the kidneys, liver, brain, and other organs. Without treatment, aspergillosis is almost invariably fatal. Even with aggressive therapy, mortality rates remain high, and the disease carries a guarded to poor prognosis in many cases.

Treatment of aspergillosis requires prolonged antifungal therapy typically lasting weeks to months, combined with supportive care and correction of underlying predisposing factors. The disease is much easier to prevent than to treat, making attention to environmental management, stress reduction, and immune support critical for raptor health. Early detection significantly improves treatment outcomes, but diagnosis can be challenging as early symptoms are often subtle and nonspecific. Working with a veterinarian experienced in raptor medicine is essential for both prevention and treatment of this serious condition.

Aspergillosis in raptors is caused by opportunistic fungi belonging to the genus Aspergillus, with Aspergillus fumigatus responsible for the vast majority of cases. Other species including Aspergillus flavus, Aspergillus niger, and Aspergillus terreus occasionally cause infection, sometimes with different clinical presentations or antifungal susceptibility patterns. These fungi produce enormous numbers of microscopic spores called conidia that become airborne and are inhaled by birds during normal respiration. In healthy raptors with competent immune systems, inhaled spores are typically cleared by respiratory defenses without causing disease. However, when spore exposure is overwhelming or immune function is compromised, infection becomes established.

Environmental factors play a crucial role in aspergillosis development, as the causative fungi are present throughout the environment. Aspergillus thrives in decaying organic material including moldy hay, straw, wood chips, and decomposing vegetation. Improperly stored grain or seed used for prey animal feed can become heavily contaminated with fungal spores. Inadequate ventilation in raptor housing allows spore concentrations to build up to dangerous levels. Dusty conditions and poor air quality increase both spore exposure and respiratory irritation that may facilitate infection. Proximity to agricultural operations, compost facilities, or areas with heavy organic matter decay increases environmental spore loads.

Immune suppression represents the most critical risk factor for aspergillosis development in raptors. Stress is the predominant cause of immune compromise in captive and rehabilitating birds of prey. Capture stress, transportation, handling, captivity itself, inadequate housing, improper diet, and the stress of injury or concurrent illness all suppress immune function and predispose birds to fungal infection. Malnutrition, particularly deficiencies in vitamin A, compromises the integrity of respiratory epithelium and reduces immune competence. Concurrent infections with bacteria, viruses, or parasites tax the immune system and may allow opportunistic fungal establishment. Corticosteroid administration, sometimes used inappropriately in raptors, dramatically increases aspergillosis susceptibility.

Certain raptor species demonstrate markedly higher susceptibility to aspergillosis, likely due to both physiological and ecological factors. Gyrfalcons are notoriously vulnerable and may develop infection rapidly even with relatively modest spore exposure. Snowy Owls, Rough-legged Hawks, and other Arctic species appear particularly at risk, possibly because they evolved in cold, relatively spore-free environments and lack the immune adaptations of species from warmer climates. Red-tailed Hawks, Golden Eagles, and many other commonly kept falconry birds are also regularly affected. Young birds, especially recently captured or recently fledged individuals under stress, show increased vulnerability. Birds with penetrating injuries, particularly air sac trauma, are at elevated risk for localized aspergillosis at wound sites.

The pathogenesis of aspergillosis involves inhalation of fungal conidia that reach the lower respiratory tract and air sacs. In immunocompromised birds, spores germinate and produce invasive hyphae (fungal filaments) that penetrate tissue. The bird's immune system mounts an inflammatory response, attempting to wall off the infection through granuloma formation. These granulomas, called aspergillomas, consist of fungal material surrounded by inflammatory cells and fibrous tissue. As infection progresses, granulomas enlarge and may coalesce, progressively replacing normal respiratory tissue. Fungal toxins and the inflammatory response cause tissue necrosis and impaired gas exchange. In advanced cases, fungal invasion of blood vessels leads to hematogenous spread and systemic infection affecting distant organs. The relatively avascular nature of air sacs limits immune cell and antifungal drug penetration, contributing to the difficulty of treating established infections.

Early warning signs of aspergillosis in raptors are notoriously subtle and easily overlooked, contributing to delayed diagnosis and poorer outcomes. Initial symptoms may include slight changes in attitude or energy levels, with affected birds appearing somewhat quieter or less alert than normal. Subtle decreases in appetite often precede more obvious signs, with birds showing less enthusiasm for food or leaving small amounts uneaten. Mild exercise intolerance may manifest as increased respiratory effort or open-mouth breathing after routine activity that previously caused no distress. Some birds show subtle voice changes, with calls becoming slightly hoarse or different in quality. These early signs are easily attributed to stress, weather changes, or minor issues, making vigilance essential for early detection. Because raptors, like all birds, instinctively mask signs of illness to avoid appearing vulnerable to predators or rivals, owners must learn to recognize subtle behavioral changes that signal developing problems.

Respiratory symptoms become progressively apparent as aspergillosis advances. Increased respiratory rate (tachypnea) and labored breathing (dyspnea) develop as lung and air sac function becomes compromised. Affected birds may show tail-bobbing, a distinctive up-and-down movement of the tail with each breath that indicates significant respiratory effort. Open-mouth breathing at rest, particularly concerning in raptors, indicates severe respiratory compromise. Audible respiratory sounds including clicking, wheezing, or squeaking may be heard, especially during exertion. In cases affecting the syrinx, voice changes become pronounced, with complete loss of voice possible. Nasal discharge may occur in some cases, though this is more common with bacterial or other respiratory infections.

Behavioral changes accompanying aspergillosis reflect the bird's declining condition and discomfort. Affected raptors become progressively lethargic, spending increased time on perches with little movement or activity. Appetite decreases, and birds may refuse food entirely as disease progresses. Weight loss becomes evident, with loss of pectoral muscle mass creating a prominent keel bone. Sick birds often fluff their feathers and appear hunched, attempting to conserve body heat as their metabolism becomes impaired. Flying becomes difficult and eventually impossible as respiratory function deteriorates. Some birds may show increased aggression or defensive behavior due to feeling unwell, while others become unusually passive and easy to handle.

Physical signs observable on examination include changes in body condition with muscle wasting, particularly over the pectoral region. Feather quality may decline, appearing dull or unkempt due to reduced preening. Abdominal distension can occur in cases with air sac involvement or secondary complications. Dehydration becomes evident in advanced cases, with dull eyes and loss of skin elasticity. Oral examination may reveal plaques or granulomas in the choana (opening between oral and nasal cavities) or throat in some cases. Neurological signs including head tilt, ataxia, or seizures indicate central nervous system involvement in disseminated infections.

Symptom progression in aspergillosis follows a relentlessly deteriorating course without treatment. Acute aspergillosis, more common in overwhelming exposures or highly susceptible individuals, may progress from apparent health to severe illness within days. Chronic aspergillosis develops insidiously over weeks to months, with gradual worsening that may initially seem like general decline rather than specific disease. Both forms eventually lead to severe respiratory compromise, cachexia, and death if untreated. The rapidity of decline often accelerates in late stages as accumulated tissue damage overwhelms remaining compensatory capacity.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with open-mouth breathing at rest, cyanosis (bluish coloration of mucous membranes indicating oxygen deprivation), complete anorexia lasting more than twenty-four hours, profound weakness or inability to perch, and any neurological abnormalities. Collapse or loss of consciousness constitutes an immediate emergency. Sudden dramatic worsening after a period of apparent stability suggests acute respiratory obstruction or cardiovascular compromise and requires urgent intervention. At this stage, aggressive emergency stabilization including oxygen therapy, supportive fluids, and antifungal treatment offers the only hope of survival, though prognosis remains guarded even with optimal care.

Initial examination of a raptor suspected of aspergillosis begins with comprehensive history taking and physical assessment. The veterinarian will inquire about the bird's origin, duration in captivity, housing conditions, diet, any recent stressors or changes, and the timeline and progression of symptoms. Species is particularly relevant given the known susceptibility differences among raptors. Physical examination includes careful auscultation of the respiratory system, evaluation of body condition, assessment of hydration status, and examination of the oral cavity for plaques. The veterinarian will note respiratory rate and effort, any audible respiratory sounds, and the bird's overall attitude and strength. However, physical examination alone cannot definitively diagnose aspergillosis, and additional diagnostics are essential.

Imaging studies provide crucial information about the extent of respiratory involvement. Radiographs (X-rays) may reveal increased density in the lungs or air sacs, representing granulomas or inflammatory infiltrates. Air sac thickening, haziness of normally clear air sac spaces, or discrete granulomatous masses may be visible. However, early aspergillosis may produce minimal radiographic changes, and normal radiographs do not rule out disease. Endoscopy offers direct visualization of the respiratory system and is considered the gold standard for aspergillosis diagnosis in raptors. Using a rigid endoscope, the veterinarian can examine the trachea, syrinx, lungs, and air sacs, visualizing characteristic granulomas or fungal plaques and obtaining samples for laboratory confirmation. Endoscopy also allows assessment of disease extent and severity.

Laboratory diagnostics help confirm aspergillosis and assess the bird's overall condition. Complete blood count often reveals heterophilia (elevated heterophils, the avian equivalent of neutrophils) and monocytosis, indicating chronic inflammation. Protein electrophoresis typically shows elevated globulins, reflecting the immune response to infection. Aspergillus antigen testing (galactomannan assay) can detect fungal components in blood, providing support for diagnosis when positive, though false negatives occur in early or localized disease. Beta-D-glucan testing offers another serological marker of fungal infection. Culture of samples obtained at endoscopy or from tracheal wash specimens can grow and identify the specific Aspergillus species, though culture is slow and may require special laboratory techniques. PCR testing for Aspergillus DNA provides rapid molecular confirmation.

Differential diagnosis of respiratory disease in raptors includes several other conditions that may present similarly. Bacterial respiratory infections, including those caused by Pseudomonas, Klebsiella, and other organisms, can produce dyspnea and radiographic changes. Avian influenza and other viral respiratory diseases must be considered in some contexts. Parasitic respiratory disease, including air sac mites (Sternostoma) and respiratory nematodes, causes respiratory signs particularly in wild-caught birds. Cardiac disease can produce respiratory distress through pulmonary congestion. Inhaled foreign bodies or traumatic air sac injuries may mimic aspergillosis symptoms. Thorough diagnostic workup including imaging, endoscopy, and laboratory testing allows differentiation of these conditions. Following definitive diagnosis, the veterinarian will stage disease severity, typically categorizing cases as localized (focal granulomas) or disseminated (widespread involvement), which guides treatment planning and prognostic assessment.

Emergency stabilization of raptors presenting in respiratory distress from aspergillosis requires immediate supportive intervention. Oxygen supplementation is essential for birds showing cyanosis, severe dyspnea, or weakness, provided through an oxygen cage, mask, or flow-by delivery. Handling must be minimized as stress can precipitate respiratory arrest in severely compromised birds. Heat support maintains body temperature in debilitated patients. Fluid therapy addresses dehydration and supports circulation. In cases with obstructive granulomas in the syrinx or trachea, emergency surgical removal may be required to establish airway patency. Once immediate stabilization is achieved, comprehensive antifungal therapy can be initiated.

Systemic antifungal medication forms the cornerstone of aspergillosis treatment in raptors. Voriconazole has emerged as the antifungal of choice for avian aspergillosis, offering excellent tissue penetration including into air sacs and central nervous system, with good efficacy against Aspergillus fumigatus. Treatment typically begins at dosages established through pharmacokinetic studies in raptors, administered orally once daily. Itraconazole serves as an alternative, though some studies suggest inferior efficacy compared to voriconazole. Amphotericin B, though historically used, causes significant nephrotoxicity and is generally reserved for cases unresponsive to azole antifungals. Treatment duration extends for months, typically continuing for at least four to eight weeks beyond resolution of clinical signs and normalization of diagnostic parameters. Premature discontinuation frequently results in relapse.

Surgical intervention may be beneficial in select aspergillosis cases. Debulking of large, accessible granulomas through endoscopic or open surgery reduces fungal burden and may improve response to antifungal therapy. Syringeal granulomas causing voice changes or airway obstruction can sometimes be removed endoscopically. Air sac granulomas may be accessible through air sacculotomy, though this invasive procedure carries significant risks. Surgery is generally considered for localized, accessible lesions in otherwise stable patients rather than disseminated disease. Post-surgical antifungal therapy remains essential as surgery alone does not eliminate microscopic infection.

Nebulization therapy delivers antifungal medication directly to respiratory surfaces and represents an important adjunctive treatment. Clotrimazole or amphotericin B nebulized into respiratory passages achieves high local drug concentrations with minimal systemic absorption or toxicity. Treatment typically involves fifteen to thirty minute sessions once or twice daily, continued throughout the treatment course. Nebulization is particularly valuable for upper airway and air sac disease where systemic drugs may achieve lower tissue concentrations. A small nebulizer chamber or face mask delivery system allows practical administration for individual raptors.

Supportive care measures complement antifungal therapy and may significantly impact outcomes. Nutritional support ensures adequate caloric intake, with assist-feeding required for anorectic birds. High-quality whole prey items provide optimal nutrition for recovering raptors. Vitamin supplementation, particularly vitamin A, supports respiratory epithelial integrity and immune function. Environmental modifications eliminate ongoing spore exposure by ensuring clean, well-ventilated housing with appropriate substrate. Stress reduction through minimal handling, appropriate housing, and attention to behavioral needs supports immune function. Treatment of concurrent conditions, whether injuries, parasites, or other infections, eliminates factors compromising immune competence.

Treatment decisions in aspergillosis consider multiple factors beyond medical management. The severity and extent of disease strongly influence prognosis, with disseminated aspergillosis carrying much poorer outcomes than localized disease. The value and purpose of the bird may influence the intensity of treatment pursued, though all affected raptors deserve appropriate care. Cost considerations are significant given the prolonged treatment duration, multiple medications, and repeated diagnostics required. Owner commitment to extended treatment protocols, including daily medication administration and multiple veterinary rechecks, is essential for success. The veterinarian helps owners understand realistic expectations, with honest discussion of prognosis and the possibility of treatment failure despite optimal effort.

Recovery from aspergillosis in raptors requires extraordinary patience, as successful treatment extends over months rather than weeks. Initial response to antifungal therapy may become apparent within the first two weeks, with stabilization or improvement in respiratory effort, appetite, and activity level. However, resolution of granulomatous lesions is a slow process, with radiographic and endoscopic improvement lagging behind clinical improvement. Complete treatment courses typically range from eight to sixteen weeks or longer, with duration guided by repeated assessment of clinical condition, laboratory parameters, and imaging or endoscopic findings. Premature treatment discontinuation is a common cause of relapse, making completion of the full prescribed course essential regardless of apparent clinical recovery.

Post-treatment care following aspergillosis therapy focuses on rebuilding condition while maintaining vigilance for relapse. Gradual return to full activity allows respiratory capacity to recover alongside tissue healing. Weight and muscle mass monitoring guides nutritional support during rebuilding. Flight conditioning progresses incrementally, starting with short flights and gradually increasing duration and intensity as stamina improves. Follow-up examinations at regular intervals, typically monthly for the first three months post-treatment, assess for any evidence of recurrence. Laboratory monitoring including complete blood count and protein electrophoresis helps confirm resolution of inflammation. Some veterinarians recommend follow-up endoscopy to verify granuloma resolution before declaring treatment success.

Prognostic factors in aspergillosis significantly influence expected outcomes. Early-stage, localized disease carries the best prognosis, with survival rates potentially exceeding fifty percent in promptly diagnosed cases with aggressive treatment. Disseminated aspergillosis with multi-organ involvement carries a poor prognosis despite treatment, with mortality often exceeding seventy to eighty percent. Species susceptibility affects outlook, with Gyrfalcons and other highly susceptible species often faring worse than species with apparent natural resistance. The underlying cause of immune compromise influences prognosis; birds stressed by temporary factors like capture may recover well, while those with ongoing predisposing conditions face greater challenges. Treatment response within the first two weeks provides prognostic information, with failure to improve suggesting poor outcome.

Long-term outlook for aspergillosis survivors generally includes return to normal function for many recovered birds, though some retain residual respiratory compromise. Relapse remains possible even after apparently successful treatment, typically occurring within the first six months after therapy completion. Survivors may have permanent air sac scarring visible on imaging, though this may not cause clinical impairment. Birds returned to falconry or breeding can often perform normally, though careful attention to stress management and environmental conditions reduces relapse risk. Lifelong attention to predisposing factors helps protect recovered birds from reinfection. Regular veterinary monitoring throughout the bird's life provides early warning of any recurrence.

Environmental prevention of aspergillosis focuses on reducing Aspergillus spore exposure while maintaining raptor housing conducive to health. Housing facilities should provide excellent ventilation, allowing fresh air exchange while preventing drafts that stress birds. Substrates should be chosen carefully, avoiding materials prone to harboring fungi such as hay, straw, and decomposing organic matter. Clean sand, pea gravel, or astroturf provide suitable alternatives that are easily maintained. Regular cleaning prevents accumulation of organic material where fungi can grow. Storage of prey items and feeding supplies in clean, dry conditions prevents mold contamination. Location of raptor facilities away from compost areas, agricultural dust sources, and other fungal reservoirs reduces environmental spore loads. Air filtration may benefit facilities in high-spore environments.

Quarantine and evaluation protocols for new raptors help identify and address aspergillosis risk before birds become part of established collections. Newly acquired raptors, whether captive-bred or wild-caught, should undergo thorough veterinary examination including respiratory evaluation. Quarantine for a minimum of thirty days allows observation for developing disease and prevents potential spread of other infections. Baseline diagnostics including complete blood count and radiographs establish reference values and may detect subclinical disease. Birds showing any respiratory abnormalities require full diagnostic workup before leaving quarantine. Wild-caught raptors entering rehabilitation or falconry face particular risk due to capture stress and benefit from enhanced monitoring and supportive care during the transition to captivity.

Nutritional excellence supports immune function and respiratory epithelial health critical for aspergillosis resistance. Whole prey feeding provides complete nutrition superior to prepared diets for most raptor keeping purposes. Prey quality matters, with clean, healthy prey animals offering optimal nutrition. Vitamin A adequacy is particularly important for respiratory epithelium integrity; deficiency is common in raptors fed prey raised on deficient diets. Supplementation may be warranted based on diet analysis and veterinary recommendation. Variety in prey species provides balanced nutrition and reduces risk of specific deficiencies. Feeding schedules appropriate to species and condition maintain body weight without the stress of either hunger or obesity.

Health maintenance and immune support reduce aspergillosis vulnerability in captive raptors. Regular veterinary examinations, at minimum annually for healthy birds, allow early detection of developing problems. Parasite control eliminates a source of chronic immune drain. Prompt treatment of injuries, infections, and other health issues prevents prolonged immune suppression. Stress reduction through appropriate housing, proper management, and attention to behavioral needs supports natural immunity. Avoidance of unnecessary corticosteroid use eliminates a major iatrogenic risk factor. For highly susceptible species or birds with history of aspergillosis, prophylactic antifungal therapy during high-risk periods such as stress or illness may be considered in consultation with an avian veterinarian.

Early intervention when aspergillosis is suspected dramatically improves outcomes. Any respiratory abnormality in a raptor warrants immediate veterinary attention, with aspergillosis considered in the differential diagnosis. Declining appetite, reduced activity, or voice changes prompt evaluation rather than watchful waiting. For raptors under significant stress, such as newly captured birds or those undergoing rehabilitation from injuries, prophylactic antifungal therapy may prevent infection establishment. Baseline endoscopy for high-risk individuals allows detection of early lesions before clinical signs develop. Building relationships with veterinarians experienced in raptor medicine before emergencies occur ensures rapid access to appropriate care when concerns arise.

Daily management of raptors with aspergillosis during treatment requires careful attention to medication administration, monitoring, and supportive care. Antifungal medications must be given consistently at prescribed times and dosages, typically once daily for oral azole antifungals. Medication can usually be hidden in prey items for voluntary consumption, though tube-feeding may be necessary for anorectic patients. Nebulization sessions, if prescribed, require dedicated equipment and consistent scheduling. Daily observations should note appetite, activity level, respiratory effort, droppings character, and any changes in condition. Weight monitoring, ideally daily during active treatment, provides objective assessment of nutritional status. Records of all observations help track progress and identify trends that inform veterinary reassessment.

Home environment optimization supports recovery while minimizing ongoing spore exposure. Housing should emphasize cleanliness and air quality above all other considerations during treatment. Substrates must be immaculately maintained, with immediate removal of droppings, uneaten food, and any debris. Excellent ventilation ensures fresh air circulation without drafts that stress recovering birds. Temperature should be maintained slightly warmer than normal to reduce metabolic demands on compromised patients. Quiet location away from disturbances reduces stress. Humidity management prevents both excessive dryness that irritates respiratory passages and dampness that promotes fungal growth. Outdoor weathering, normally beneficial, may be limited during recovery to reduce environmental exposure risks.

Maintaining quality of life during prolonged aspergillosis treatment balances recovery needs with the bird's behavioral welfare. Even sick raptors benefit from visual stimulation and environmental interest, which can be provided through appropriate perching variety and visual access to outdoor activity. Social contact with caretakers, while minimized to reduce handling stress, should maintain bonds important for training and management. As recovery progresses, graduated return to normal activities including flying provides both physical conditioning and mental stimulation. Creative enrichment appropriate to the individual bird's condition helps prevent boredom during extended convalescence. Throughout treatment, attention to the individual raptor's behavioral signals guides management adjustments.

Ongoing monitoring and veterinary care extend throughout treatment and beyond into the recovery period. Scheduled recheck examinations, typically every two to four weeks during active treatment, assess progress and guide therapy adjustments. Repeat diagnostics including blood work monitor for treatment response and drug toxicity. Imaging or endoscopy at intervals determined by the veterinarian assesses granuloma resolution. After treatment completion, follow-up examinations at one, three, and six months help detect any relapse early. Any deterioration in condition between scheduled examinations warrants immediate veterinary contact. Maintaining detailed records of treatment administration, weight, and clinical observations provides valuable information for veterinary assessments.

Caregiver support resources help falconers and raptor keepers manage the significant demands of aspergillosis treatment. Treatment courses extending over months require substantial time commitment, emotional investment, and financial resources. Connecting with experienced falconers who have navigated aspergillosis treatment provides practical advice and emotional support. Veterinary clinic staff can often help problem-solve administration challenges and address concerns between appointments. Online communities and falconry organizations offer forums for sharing experiences and learning from others' cases. Realistic expectations about prognosis, honestly discussed with the veterinarian, help caregivers prepare for possible outcomes. Recognizing signs of caregiver fatigue and seeking support when needed protects both human and avian welfare during this challenging process.

Gyrfalcons represent the species most famously susceptible to aspergillosis among raptors, with vulnerability so pronounced that the disease significantly impacts both falconry populations and conservation breeding programs. Native to Arctic regions with minimal fungal exposure, Gyrfalcons appear to lack robust immune adaptations to Aspergillus present in species from temperate and tropical environments. Captive Gyrfalcons face constant risk, particularly during times of stress such as breeding season, moult, or climate adjustment. Even minimal fungal exposure that would not affect most raptors can prove fatal in this species. Gyrfalcon keepers must maintain exceptionally clean environments with meticulous attention to substrate, ventilation, and spore sources. Some falconers advocate prophylactic antifungal therapy during high-risk periods for this species.

Other Arctic and northern species share elevated aspergillosis susceptibility, including Snowy Owls, Rough-legged Hawks, and Northern Goshawks from northern populations. The same evolutionary pressure that protected these species from fungal disease in their native environments leaves them vulnerable when kept in or passing through temperate regions. Snowy Owls in rehabilitation settings experience high aspergillosis rates, often developing infection secondary to the stress of injury and captivity. Migration through agricultural areas may expose northern species to heavy spore loads during already stressful journeys. Climate considerations in housing these species may help reduce risk, with cooler temperatures potentially supporting immune function while reducing fungal growth.

Many commonly kept falconry species including Red-tailed Hawks, Harris's Hawks, and various falcon species develop aspergillosis with significant frequency, though not with the extreme susceptibility seen in Arctic species. Young birds entering captivity face particular risk during the stressful transition from wild-caught or newly fledged state. Rehabilitation centers see high aspergillosis rates across species, reflecting the immune compromise associated with injury and captivity stress. Even captive-bred raptors maintained under optimal conditions occasionally develop aspergillosis, particularly during stressful events such as breeding attempts, facility changes, or concurrent illness.

Screening and monitoring recommendations vary by species susceptibility and individual risk factors. Highly susceptible species like Gyrfalcons benefit from baseline endoscopy before acquisition and periodic screening thereafter, with immediate evaluation at any sign of illness. All newly acquired raptors should undergo thorough veterinary examination with particular attention to respiratory status. Baseline diagnostics establishing normal parameters for each individual enable recognition of early changes. During high-risk periods such as post-acquisition, breeding season, or concurrent illness, enhanced vigilance and possibly prophylactic therapy may be warranted. Rehabilitation centers should implement screening protocols for incoming birds and maintain heightened surveillance throughout the rehabilitation process. Building strong relationships with experienced avian veterinarians ensures appropriate monitoring and rapid response when concerns arise.

Bacterial respiratory infections commonly co-occur with or complicate aspergillosis in raptors. Bacteria including Pseudomonas aeruginosa, Klebsiella pneumoniae, and various other species may establish secondary infections in respiratory tissue damaged by fungal invasion. Distinguishing primary bacterial infection from secondary infection complicating aspergillosis requires careful diagnostic evaluation including culture. Treatment of concurrent bacterial infection alongside antifungal therapy may be necessary for optimal outcomes. Antibiotic selection should be guided by culture and sensitivity results given the potential for resistant organisms. The immunosuppression predisposing to aspergillosis similarly increases vulnerability to bacterial pathogens.

Several conditions present with symptoms similar to aspergillosis and must be considered in differential diagnosis. Bacterial air sacculitis caused by various organisms produces respiratory signs overlapping with aspergillosis. Avian mycobacteriosis (tuberculosis) can cause granulomatous respiratory disease mimicking aspergillosis. Parasitic respiratory disease, including Serratospiculum infections in falcons and air sac mites in smaller species, causes respiratory compromise. Neoplastic conditions including carcinoma and lymphoma occasionally affect respiratory tissues. Tracheal foreign bodies or injuries may produce respiratory distress and voice changes. Cardiac disease can cause respiratory compromise through pulmonary congestion. Thorough diagnostic workup including endoscopy, imaging, and laboratory testing differentiates these conditions.

Potential complications of aspergillosis extend beyond respiratory involvement to affect multiple body systems. Systemic dissemination spreads fungal infection to kidneys, liver, brain, and other organs, dramatically worsening prognosis. Central nervous system involvement causes neurological signs including head tilt, ataxia, seizures, and behavioral changes. Renal aspergillosis may cause kidney failure with associated systemic consequences. Eye involvement can lead to visual impairment or blindness. Vertebral aspergillosis causes spinal cord compression with progressive paralysis. Treatment complications include antifungal drug toxicity, particularly hepatotoxicity from azole antifungals requiring monitoring. Relapse following apparently successful treatment occurs in a significant percentage of cases, typically within six months of treatment completion. Chronic respiratory scarring may permanently limit function even in successfully treated survivors.